trending Market Intelligence /marketintelligence/en/news-insights/trending/LrTtTpGr2L1EeBOHz_khkw2 content esgSubNav
In This List

CohBar appoints director

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


CohBar appoints director

CohBar Inc. appointed John Amatruda to the board.

Amatruda is a co-founder and scientific adviser to the company. He is also currently on the board of CureDM, Prosciento, and Fractyl.

CohBar is a biotechnology company focused on the research and development of mitochondria-based therapeutics for age-related diseases.